Belgium· BE-AMP-SAM119822-00
Amsidine 75 mg/1.5 ml
A amsacrine product containing amsacrine, registered in Belgium by Eurocept International. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Amsacrine is registered in 10 of 19 countries.
Countries holding a registration under ATC L01XX01 (amsacrine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Amsacrine · ATC L01XX01
10 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Amsacrine
- Manufacturer
- Eurocept International
- Country
- Belgium (BE)
- ATC code
- L01XX01
- ATC class
- Amsacrine
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb2755288
- be_apb7708431
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amsacrine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAmekrinEurocept International BV
- United KingdomAmsidine 75mg/1.5ml concentrate and solvent for solution for infusion vialsEurocept International bv
- NorwayAmlyoEurocept
- GermanyAmlyoEurocept International Bv
- IcelandAmsalyoEurocept International B.V.
- NetherlandsAmsalyo 75 mg poeder voor concentraat voor oplossing voor infusieEurocept International B.V.
- SwedenAmsalyo 75 mg Pulver till koncentrat till infusionsvätska, lösningEurocept International B.V.
- SpainAMEKRIN 75 MG/1,5 ML CONCENTRADO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONEurocept International B.V.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Amlyo
- Germany · Amlyo, Amsidyl
- Denmark · Amsalyo
- Finland · Amsalyo
- France · Amsalyo
- Croatia · Amlyo
- Ireland · Amsalyo
- Iceland · Amsalyo
- Italy · Amsalyo
- Luxembourg · Amsalyo
- Netherlands · Amsalyo
- Norway · Amsalyo
- Sweden · Amsalyo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/876e8713-040e-48f9-8c42-8e0e8c002b69 GET /v1/drugs/876e8713-040e-48f9-8c42-8e0e8c002b69?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate and solvent for concentrate for solution for infusion",
"source": "afmps",
"status": "REVOKED",
"name_en": "Amsidine 75 mg/1.5 ml",
"name_fr": "Amsidine 75 mg/1.5 ml",
"name_nl": "Amsidine 75 mg/1.5 ml",
"amp_code": "SAM119822-00",
"strengths": [
"75.0000",
"75.0000"
],
"pack_count": 2,
"substances": [
"Amsacrine"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Amsacrine",
"authorisation_numbers": [
"BE119822"
]
}See everything about amsacrine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.